STIM – neuronetics, inc. (US:NASDAQ)

News

Neuronetics (STIM) had its price target lowered by Canaccord Genuity Group Inc. from $7.00 to $3.00. They now have a "buy" rating on the stock.
Neuronetics, Inc. (STIM) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Neuronetics outlines >9% 2026 revenue growth target while piloting new TMS models and preparing for Compass therapy launch [Seeking Alpha]
Neuronetics, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Neuronetics (STIM) Q4 2025 Earnings Transcript [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com